BioRelix's Debt Round

BioRelix raised a round of funding on December 22, 2010.

BioRelix is discovering and developing new treatments for infectious diseases that target RiboSwitches, a class of RNA drug targets found in pathogenic bacteria and fungi. Riboswitches are short stret…

Articles about BioRelix's Debt Round: